Development and Commercialization

Women & Children’s Healthcare

We are focusing on the Women & Children’s Healthcare space and growing our footprint by leveraging strategic partnering and collaboration to deliver a portfolio of diversified transformative medicines and innovative healthcare solutions across disease areas.

Our vision is to create a novel integrated R&D Hub that spans the Globe to speed Discovery to Patients for the next-generation of excellence in 21st Century health care for unmet needs in chronic and life-threatening diseases.

Uterine Fibroids

Uterine Fibroids diagnosed in up to 70% of Caucasian women and 80% of African-ancestry women

Direct costs of uterine fibroids burden $9.4 billion

Loss in work-hours $17 billion

Unmet need remains particularly during reproductive years:

Surgery avoidance – major cause of hysterectomy
Fertility preservation for women’s well being and long-term health
Long-term control and management of Heavy Menstrual Bleeding (HMB) – well tolerated for higher adherence/compliance

Development and Commercialization

Women & Children’s Healthcare

Uterine Fibroids

Endometriosis

Cancer in Women